Compliance With Dyslipidemia Guidelines in Daily Practice: How Effective Is Cardiovascular Risk Prevention?

GÜNTEKİN Ü., Gumrukcuoglu H. A., Yaman M., Öztürk F., Akyol A., Gumrukcuoglu F. N., ...Daha Fazla

CLINICAL THERAPEUTICS, cilt.40, sa.12, ss.2031-2040, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 12
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.clinthera.2018.10.002
  • Dergi Adı: CLINICAL THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2031-2040
  • Anahtar Kelimeler: cardiovascular risk level, dyslipidemia guideline, statin, CORONARY-HEART-DISEASE, STATIN THERAPY, CHOLESTEROL, DETERMINANTS, METAANALYSIS, ASSOCIATION, PERSISTENCE, POPULATION, PREVALENCE, MANAGEMENT
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: Cardiovascular disease (CVD) due to atherosclerosis is the leading cause of early mortality and morbidity. The current European guidelines on CVD prevention in clinical practice recommend the use of the Systematic Coronary Risk Estimation (SCORE) system. The current American Heart Association guidelines recommend the use of the new pooled cohort risk assessment equations to estimate the 10-year atherosclerotic CVD risk. The purpose of this article was to investigate the compliance of dyslipidemia guidelines in daily practice in patients with dyslipidemia or who have risk factors for CVD.